Galapagos Revenue and Competitors
Estimated Revenue & Valuation
- Galapagos's estimated annual revenue is currently $526.2M per year.
- Galapagos's estimated revenue per employee is $363,900
- Galapagos's total funding is $5.4B.
- Galapagos's current valuation is $3.6B. (January 2022)
Employee Data
- Galapagos has 1446 Employees.
- Galapagos grew their employee count by -9% last year.
Galapagos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Project Leader, VP | Reveal Email/Phone |
2 | Head Biometrics, VP | Reveal Email/Phone |
3 | CFO & COO | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | CFO and COO | Reveal Email/Phone |
6 | Chief Staff | Reveal Email/Phone |
7 | Head Medical Writing | Reveal Email/Phone |
8 | Procurement Officer | Reveal Email/Phone |
9 | Head QM R&D Immunology | Reveal Email/Phone |
10 | VP Late Development Portfolio | Reveal Email/Phone |
Galapagos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.6M | 66 | N/A | N/A | N/A |
What Is Galapagos?
Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos? pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications. Our target discovery platform has delivered three novel mechanisms showing promising patient results in, respectively, inflammatory diseases, idiopathic fibrosis and atopic dermatitis. Galapagos is focused on the development and commercialization of novel medicines that will improve people?s lives. The Galapagos group, including fee-for-service subsidiary Fidelta, has approximately 675 employees, operating from its Mechelen, Belgium headquarters and facilities in the Netherlands, France, Switzerland, the USA and Croatia. More information at www.glpg.com.
keywords:N/A
$5.4B
Total Funding
1446
Number of Employees
$526.2M
Revenue (est)
-9%
Employee Growth %
$3.6B
Valuation
N/A
Accelerator
Galapagos News
Here is how Galapagos NV (GLPG) and MedAvail Holdings, Inc. (MDVL) have performed compared to their sector so far this year.
Both dense human populations and a plethora of wildlife can pose a challenge to marine and public health in the Galápagos Islands.
A boat carrying barrels of diesel fuel has sank near one of Ecuador's ecologically sensitive Galapagos Islands, according to officials.
Galapagos increases share capital through subscription right exercises Mechelen, Belgium; 20 September 2021, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises. Galapagos issued 7,600 new ordina ...
GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS Mechelen, Belgium; 17 September 2021; 13.15 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the European Medicines Agency's (EM ...